Pedunculoside Inhibits Hepatocellular Carcinoma Progression by Activating the MAPK Signaling Pathway Through Targeting and Suppressing CDK4
{{output}}
Hepatocellular carcinoma (HCC) remains a major challenge in cancer prevention and treatment, highlighting the urgent need for effective and low-toxicity anti-HCC therapies. Recently, CDK4-targeted inhibitors have shown promise in the treatment of HCC. Our stud... ...
